Fate Therapeutics, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $46.6M | $36.1M | $41.9M | $61.3M | $133.6M | $167.3M | $99.8M | $190.5M |
| Accounts Receivable | $916.0K | $3.5M | $1.8M | $38.5M | $8.7M | $5.5M | — | $500.0K |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $208.7M | $291.9M | $331.5M | $502.1M | $633.4M | $494.3M | $227.1M | $205.2M |
| Property, Plant & Equipment | $56.9M | $64.4M | $96.8M | $110.0M | $91.5M | $32.3M | $11.4M | $5.1M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $318.9M | $440.7M | $506.2M | $705.6M | $921.5M | $622.5M | $302.3M | $213.0M |
| Liabilities | ||||||||
| Accounts Payable | $2.7M | $9.4M | $4.7M | $8.3M | $8.6M | $6.3M | $5.8M | $4.2M |
| Total Current Liabilities | $36.1M | $38.5M | $39.1M | $114.1M | $81.3M | $85.6M | $27.8M | $27.3M |
| Long-Term Debt | — | — | — | — | — | — | — | $12.4M |
| Total Liabilities | $111.8M | $122.0M | $137.8M | $221.6M | $242.6M | $238.0M | $57.5M | $52.6M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-1.53B | $-1.40B | $-1.21B | $-1.05B | $-769.1M | $-556.9M | $-383.5M | $-285.4M |
| Total Stockholders' Equity | $207.2M | $318.7M | $368.4M | $483.9M | $678.8M | $384.4M | $244.8M | $160.5M |